Dr. Heather Ann Wakelee M.D.

Fellowships

• Stanford University Medical Center, Stanford Ca - Bariatric Surgery   2003

Publications

• JOURL OF THORACIC ONCOLOGYA Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib2012
• JOURL OF CLINICAL ONCOLOGYLung cancer incidence in never smokers2007
• Anti-cancer drugsPhase I and pharmacokinetic study of bexarotene in combition with gefitinib in the third2013
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKA Patient With Aplastic Lymphoma Kise-Positive Non2013
• JOURL OF THORACIC ONCOLOGYA Case Series of NSCLC Patients with Different Molecular Characteristics2013
• LUNG CANCERA phase II study of enzastaurin in combition with erlotinib in patients with previously treated2012
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors2012
• BRITISH JOURL OF CANCERA phase I dose-escalation study of aflibercept administered in combition with pemetrexed2012
• LUNG CANCERDifferential effect of age on survival in advanced NSCLC in women versus men2012
• Clinical advances in hematology & oncology : H&OMetastatic non-small cell lung cancer magement: novel targets and recent clinical advances.2012
• CANCER INVESTIGATIONMaintence Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced2012
• JOURL OF THORACIC ONCOLOGYXL647-A Multitargeted Tyrosine Kise Inhibitor Results of a Phase II Study in Subjects with Non2012
• CLINICS IN CHEST MEDICINECurrent Magement of Small Cell Lung Cancer2011
• JOURL OF CLINICAL ONCOLOGYAmerican Society of Clinical Oncology Provisiol Clinical Opinion2011
• JOURL OF THORACIC ONCOLOGYTumor Volume as a Potential Imaging-Based Risk2011
• CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONSurvival following Non-Small Cell Lung Cancer among Asian2011
• JOURL OF THORACIC ONCOLOGYA Phase II First-Line Study of Gemcitabine, Carboplatin2010
• ANLS OF ONCOLOGYPhase I and pharmacokinetic study of lexatumumab2010
• CURRENT OPINION IN INVESTIGATIOL DRUGSRamucirumab, a fully human mAb to the transmembrane sigling tyrosine kise VEGFR2009
• ANLS OF ONCOLOGYGemcitabine and pemetrexed administered in rapid sequence as front2009
• JOURL OF THORACIC ONCOLOGYOsteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer2009
• BIODRUGSMonoclol Antibodies Targeting Vascular Endothelial Growth Factor Current Status2009
• Semirs in thoracic and cardiovascular surgeryAdjuvant chemotherapy for resected non-small cell lung cancer.2008
• JOURL OF THORACIC ONCOLOGYSummary statement - Novel Agents in the Treatment of Lung Cancer2008
• JOURL OF THORACIC ONCOLOGYAntibodies to vascular endothelial growth factor in non-small cell lung cancer2008
• Jourl of clinical oncologyLung cancer presenting with amegakaryocytic thrombocytopenia.2008
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSMetabolic tumor burden predicts for disease progression and death in lung cancer2007
• JOURL OF THORACIC ONCOLOGYAdjuvant chemotherapy of stage I non-small cell lung cancer in North America2007
• Current treatment options in oncologyRole of anti-angiogenesis agents in treating NSCLC2007
• JOURL OF THORACIC ONCOLOGYResults of a phase I dose-escalation study using single2006
• CLINICAL LUNG CANCERA multidiscipliry approach to magement in a patient with bilateral superior sulcus non-small2006
• JOURL OF THORACIC ONCOLOGYSurvival differences by sex for patients with advanced non2006
• CANCERChanges in the tural history of nonsmall cell lung cancer2006
• CLINICAL CANCER RESEARCHAn evaluation of tumor oxygetion2006
• JOURL OF CLINICAL ONCOLOGYPhase II study of gefitinib, fluorouracil2005
• INVESTIGATIOL NEW DRUGSA phase I trial of irinotecan2005
• AMERICAN JOURL OF PHYSIOLOGY-CELL PHYSIOLOGYDelta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines1996
• JOURNAL OF THORACIC ONCOLOGYA Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib2012
• JOURNAL OF CLINICAL ONCOLOGYLung cancer incidence in never smokers2007
• Clinical lung cancerA Case Series of Lengthy Progression-Free Survival With Pemetrexed2013
• Anti-cancer drugsPhase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third2013
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKA Patient With Anaplastic Lymphoma Kinase-Positive Non2013
• JOURNAL OF THORACIC ONCOLOGYA Case Series of NSCLC Patients with Different Molecular Characteristics2013
• EXPERT OPINION ON BIOLOGICAL THERAPYAflibercept in lung cancer2013
• LUNG CANCERA phase II study of enzastaurin in combination with erlotinib in patients with previously treated2012
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors2012
• BRITISH JOURNAL OF CANCERA phase I dose-escalation study of aflibercept administered in combination with pemetrexed2012
• Lung cancerERCC1 expression in circulating tumor cells2012
• LUNG CANCERDifferential effect of age on survival in advanced NSCLC in women versus men2012
• Clinical advances in hematology & oncology : H&OMetastatic non-small cell lung cancer management: novel targets and recent clinical advances.2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYA phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYA phase I pharmacokinetic study of bexarotene with vinorelbine2012
• CANCER INVESTIGATIONMaintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYA phase I pharmacokinetic study of bexarotene with paclitaxel2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYThe effect of bexarotene on atorvastatin pharmacokinetics2012
• CLINICAL LUNG CANCERMetabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non2012
• JOURNAL OF THORACIC ONCOLOGYXL647-A Multitargeted Tyrosine Kinase Inhibitor Results of a Phase II Study in Subjects with Non2012
• CLINICS IN CHEST MEDICINECurrent Management of Small Cell Lung Cancer2011
• JOURNAL OF CLINICAL ONCOLOGYAmerican Society of Clinical Oncology Provisional Clinical Opinion2011
• JOURNAL OF THORACIC ONCOLOGYTumor Volume as a Potential Imaging-Based Risk2011
• CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONSurvival following Non-Small Cell Lung Cancer among Asian2011
• JOURNAL OF THORACIC ONCOLOGYA Phase II First-Line Study of Gemcitabine, Carboplatin2010
• CLINICAL CANCER RESEARCHVoreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed2010
• ANNALS OF ONCOLOGYPhase I and pharmacokinetic study of lexatumumab2010
• Clement-Duchene, C., Krupitskaya, Y., Ganjoo, K., Lavori, P., Kumar, AA phase II first line study of gemcitabine2009
• CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONUncovering Disparities in Survival after Non-Small-Cell Lung Cancer among Asian2009
• CURRENT OPINION IN INVESTIGATIONAL DRUGSRamucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR2009
• Krupitskaya, Y., Ganjoo, K., Lavori, P. W., Kumar, A., Clement-DucheneA phase II first-line study of gemcitabine, carboplatin0
• ANNALS OF ONCOLOGYGemcitabine and pemetrexed administered in rapid sequence as front2009
• JOURNAL OF THORACIC ONCOLOGYOsteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer2009
• BIODRUGSMonoclonal Antibodies Targeting Vascular Endothelial Growth Factor Current Status2009
• CLINICAL LUNG CANCERCooperative Group Research Efforts in Lung Cancer 20082008
• Seminars in thoracic and cardiovascular surgeryAdjuvant chemotherapy for resected non-small cell lung cancer.2008
• LANCET ONCOLOGYSex differences in lung-cancer susceptibility: a smoke screen?2008
• JOURNAL OF THORACIC ONCOLOGYSummary statement - Novel Agents in the Treatment of Lung Cancer2008
• JOURNAL OF THORACIC ONCOLOGYAntibodies to vascular endothelial growth factor in non-small cell lung cancer2008
• CLINICAL LUNG CANCERComplications of ablative therapies in lung cancer2008
• CLINICAL LUNG CANCERCooperative group portfolio in locally advanced non-small-cell lung cancer: Are we making progress?2008
• Journal of clinical oncologyLung cancer presenting with amegakaryocytic thrombocytopenia.2008
• CLINICAL LUNG CANCERCooperative group research efforts in lung cancer: Focus on early-stage non-small-cell lung cancer2008
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSMetabolic tumor burden predicts for disease progression and death in lung cancer2007
• JOURNAL OF THORACIC ONCOLOGYAdjuvant chemotherapy of stage I non-small cell lung cancer in North America2007
• Current treatment options in oncologyRole of anti-angiogenesis agents in treating NSCLC2007
• ONCOLOGISTOptimal adjuvant therapy for non-small cell lung cancer - How to handle stage I disease2007
• JOURNAL OF THORACIC ONCOLOGYResults of a phase I dose-escalation study using single2006
• CLINICAL LUNG CANCERA multidisciplinary approach to management in a patient with bilateral superior sulcus non-small2006
• CLINICAL LUNG CANCERLung cancer in women: Exploring sex differences in susceptibility, biology2006
• CLINICAL LUNG CANCERCurrent status of adjuvant chemotherapy for stage IB non-small-cell lung cancer2006
• DRUGS OF TODAYSunitinib: A newly approved small-molecule inhibitor of angiogenesis2006
• JOURNAL OF THORACIC ONCOLOGYSurvival differences by sex for patients with advanced non2006
• CANCERChanges in the natural history of nonsmall cell lung cancer2006
• CLINICAL CANCER RESEARCHAn evaluation of tumor oxygenation2006
• Current treatment options in oncologySecond- and third-line treatments in non-small cell lung cancer.2006
• CLINICAL LUNG CANCERTargeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors2005
• CLINICAL LUNG CANCERActivity of novel cytotoxic agents in lung cancer: Epothilones and topoisomerase I inhibitors2005
• JOURNAL OF CLINICAL ONCOLOGYPhase II study of gefitinib, fluorouracil2005
• LUNG CANCERPost-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II2005
• INVESTIGATIONAL NEW DRUGSA phase I trial of irinotecan2005
• EXPERT REVIEW OF ANTICANCER THERAPYDocetaxel in advanced non-small cell lung cancer2005
• ONCOLOGISTOptimizing first-line treatment options for patients with advanced NSCLC2005
• HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICANovel approaches for the treatment of small cell lung cancer2004
• AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGYDelta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines1996

Experience & Accolades

• Associate Professor of Medicine (Oncology)the Stanford University Medical Center

Dr. Heather Ann Wakelee M.D.'s Practice location